Mayank N. Thakur
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Real-World Characteristics of Patients with Severe Asthma prior to Starting Dupilumab: The ProVENT Study.
Journal: Respiration; international review of thoracic diseases
Published: July 13, 2023
ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups.
Journal: ESMO open
Published: November 20, 2020
Reporting Clinical Trial Results of Phytomedicines in Acute Rhinosinusitis: Letter to the Editor Regarding Gottschlich S, Röschmann K, Candler H. Adv Ther (2018); 35:1023-1034. doi: 10.1007/s12325-018-0736-7.
Journal: Advances in therapy
Published: November 02, 2018
Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma.
Journal: Cancer immunology, immunotherapy : CII
Published: October 20, 2016
Saponins from Saponaria officinalis L. Augment the Efficacy of a Rituximab-Immunotoxin.
Journal: Planta medica
Published: July 09, 2016
Evaluation of hair growth promoting activity of Phyllanthus niruri.
Journal: Avicenna journal of phytomedicine
Published: December 23, 2015
Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation.
Journal: Nature communications
Published: July 09, 2015
Combinatorial approach to increase efficacy of Cetuximab, Panitumumab and Trastuzumab by dianthin conjugation and co-application of SO1861.
Journal: Biochemical pharmacology
Published: June 22, 2015
Hair Growth: Focus on Herbal Therapeutic Agent.
Journal: Current drug discovery technologies
Published: February 26, 2015
Electrophoretic mobility as a tool to separate immune adjuvant saponins from Quillaja saponaria Molina.
Journal: International journal of pharmaceutics
Published: February 18, 2015
Dianthin-EGF is an effective tumor targeted toxin in combination with saponins in a xenograft model for colon carcinoma.
Journal: Future oncology (London, England)
Published: December 05, 2014
Last Updated: 09/26/2026